Table 6.

Adjusted logistic regression analysis of the determinants of clinical anxiety and depression at follow-up

	Anxiety			Depression
	OR	95 % CI	p-value	OR	95 % CI	p-value
Baseline global QL	0.98	(0.96; 0.99)	0.01	0.99	(0.97; 1.00)	0.06
HADS Anxiety at baseline
Score <8	Reference			Reference
Score ≥8	9.80	(5.79; 16.60)	<0.001	1.63	(0.92; 2.89)	0.09
HADS Depression at baseline
Score <8	Reference			Reference
Score ≥8	1.31	(0.71; 2.43)	0.39	8.70	(4.70; 16.10)	<0.001
SOC at baseline	0.96	(0.93; 0.98)	<0.001	0.96	(0.94; 0.99)	0.005
Self-rated health, currently at baseline
(very) good	Reference			Reference
fair	1.16	(0.53; 2.54)	0.71	2.31	(0.88; 6.07)	0.09
(very) poor	1.29	(0.59; 2.85)	0.51	2.66	(1.04; 6.78)	0.04
Co-morbidity
0	Reference			Reference
1	1.38	(0.74; 2.58)	0.31	1.75	(0.88; 3.46)	0.11
≥2	0.85	(0.42; 1.71)	0.65	2.17	(1.06; 4.45)	0.03
Follow-up post diagnosis	0.49	(0.27; 0.88)	0.02	1.02	(0.54; 1.96)	0.94

Non-significant predictors including age, gender, SRH compared to 3 months ago at baseline, cancer diagnosis (yes/no), marital status, education, occupation, previous cancer in patient and hospital were excluded from the table. McFadden’s R ² = 0.37 for anxiety model and 0.38 for depression model. Hoswer and Leweshow test was 0.56 for both models

Significant results are highligthed in bold